To substantiate the potential role of TMEM160 in the pathogenesis and progression of lung cancer, we used the CRISPR/Cas9 system to silence the expression of TMEM160 in A549 cells (KO TMEM160) (Figure 7A). The gene discussed is TMEM160; the disease is lung carcinoma.